Optimal interlesion distance for 90 and 50 watt radiofrequency applications with low ablation index values: experimental findings in a chronic ovine model.
Journal Information
Full Title: Europace
Abbreviation: Europace
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Conflict of interest: C.H. and J.C. are employees of Biosense Webster, Inc. The other authors report no conflict."
Funding Disclosure
Evidence found in paper:
"Funding This study was funded by Biosense Webster, Inc., Irvine, CA, USA, as part of an Investigator-Initiated Pre-Clinical Study Program (ISS): BWI-IIS-651. Conflict of interest: C.H. and J.C. are employees of Biosense Webster, Inc. The other authors report no conflict."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025